10x Genomics, Inc. (TXG) has a market capitalization of $3.17B and trades at $24.80. The 52-week range is 6.78-23.56.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -70.9, Earnings Per Share (EPS) of $-0.35, annual revenue of $642.82M.
The stock has a beta of 2.17, operates in the Healthcare sector.
